Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-14

Clinical Trial Update: Use of Tinzaparin for Anticoagulation in Hemodialysis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reporting completion of tinzaparin use for anticoagulation during hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Innohep (tinzaparin)

Snippet

Sponsor: Christine Ribic | Conditions: Kidney Failure, Chronic | Phase 4 | Status: COMPLETED